Latest News for: aaaai
Edit
Hastings Tribune
10 Feb 2026
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel
Edit
Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting
Nasdaq Globe Newswire 10 Feb 2026
Edit
Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting
Nasdaq Globe Newswire 10 Feb 2026
... Asthma & Immunology Annual Meeting (AAAAI) being held in Philadelphia, PA, February 27-March 2, 2026.
Edit
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy
Nasdaq Globe Newswire 10 Feb 2026
Edit
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting (DBV Technologies SA)
Public Technologies 10 Feb 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 129413388) .
Edit
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
Pharmiweb 10 Feb 2026
... the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting being held February 27 – March 2, 2026 in Philadelphia, PA ... Further information about AAAAI 2026 can be found here.
Edit
Siolta Therapeutics Announces Upcoming Late Breaking Oral Presentation of Results from the Phase 2 ADORED trial at 2026 AAAAI meeting
PR Newswire 10 Dec 2025
... conjunctivitis) has been accepted as a late breaking oral presentation at the American Academy of Allergy, Asthma and Immunology (AAAAI) annual meeting in Philadelphia on February 27-March 2, 2026.
- 1